Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | GPR3 | P46089 | 1/20 | 0.42 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | RXRG | P48443 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.37 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.37 |
| ▸ | NOD2 | Q9HC29 | 1/20 | 0.37 |
| ▸ | PTPN5 | P54829 | 3/20 | 0.36 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15315585 | 0.87 | GPR3 (0.56) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15315580 | 0.87 | GPR3 (0.56) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15315583 | 0.87 | GPR3 (0.56) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15315586 | 0.87 | GPR3 (0.56) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL9916221 | 0.86 | MAPT (0.47) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL9916217 | 0.86 | MAPT (0.47) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15315582 | 0.85 | GPR3 (0.54) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15315516 | 0.85 | GPR3 (0.58) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15315526 | 0.85 | GPR3 (0.58) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 | |
| SCHEMBL15315522 | 0.85 | GPR3 (0.58) | MAPTRAB9AALDH1A1HPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10944061-B2 | Organic electroluminescent element and compound | UDC IRELAND LIMITED (IE) | 2021-03-09 | — | — | US | disclosed |
| US-20130270530-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND | UDC IRELAND LIMITED (IE) | 2013-10-17 | — | — | US | disclosed |
| US-20130270530-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT AND COMPOUND | UDC IRELAND LIMITED (IE) | 2013-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10944061-B2 | Organic electroluminescent element and compound | POU2F2, DDT, LEF1 | MAPT 713/4885RAB9A 3698/4885ALDH1A1 1094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.